GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Common Stock

Cinclus Pharma Holding AB (OSTO:CINPHA) Common Stock : kr0.92 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB Common Stock?

Cinclus Pharma Holding AB's quarterly common stock stayed the same from Jun. 2024 (kr0.90 Mil) to Sep. 2024 (kr0.90 Mil) but then increased from Sep. 2024 (kr0.90 Mil) to Dec. 2024 (kr0.92 Mil).

Cinclus Pharma Holding AB's annual common stock stayed the same from Dec. 2022 (kr0.51 Mil) to Dec. 2023 (kr0.51 Mil) but then increased from Dec. 2023 (kr0.51 Mil) to Dec. 2024 (kr0.92 Mil).

Cinclus Pharma Holding AB Common Stock Historical Data

The historical data trend for Cinclus Pharma Holding AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB Common Stock Chart

Cinclus Pharma Holding AB Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Common Stock
0.26 0.51 0.51 0.92

Cinclus Pharma Holding AB Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.51 0.90 0.90 0.92

Cinclus Pharma Holding AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Cinclus Pharma Holding AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Common Stock
Comparable Companies
OSTO:ORX OSTO:MOB OSTO:DICOT OSTO:NANEXA OSTO:ERMA OSTO:KLAR XSAT:ACUC OSTO:VIVE OSTO:ENZY OSTO:TOL ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
J8P:Germany
Address
Kungsbron 1, Stockholm, SWE, SE-111 22
Website
https://www.cincluspharma.com
Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines